Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrative Epigenomic Approach to Gene Discovery in Rhabdomyosarcoma (RMS)

NCT01466283 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01466283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01466283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrative Epigenomic Approach to Gene Discovery in Rhabdomyosarcoma (RMS)
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
Not reported
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma